A total of 374 clinical isolates ofEnterococcus spp. were characterized to determine the species distribution and vancomycin resistance. The ability of the Vitek system (bioMerieux Inc, Hazelwood, St. Louis, Mo.) to identify enterococci to the species level and to recognize vancomycin resistance by using computer software version 7.1 was evaluated. Conventional methods were used for identification and agar dilution was used for susceptibility testing, the results of which were as follows (presented as number of vancomycin-resistant isolates/number of members of that species identified): 219/234 E.faecium, 9/112 E. faecalis, 2/3 E. mundtii, 0/1 E. durans, 0/1 E. hirae, 0/1 E. raffinosis, and 0/1 E. avium. Ten enterococci were in the vancomycinintermediate category (six E. gallinarum, two E. casseliflavus, and one each ofE. faecium and E. faecalis). The V'itek GPI card correctly identified 98%o ofE.faecium isolates, 99%o ofE.faecalis isolates, and only two isolates of other enterococcal species. The GPS-TA card was 98% sensitive and 95% specific for the detection of vancomycin resistance, generating a total of four very major (1.6%) and five minor errors (1.3%).
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The resistance of enterococci to vancomycin has been reported with increasing frequency in both Europe and North America (7, 10, 11, 15, 19) . A diversity of resistance phenotypes has been described in E. faecium and E. faecalis (1, 9, 10, (20) (21) (22) (23) , and resistance has also been detected in isolates of E. gallinarum, E. casseliflavus (6, 14, 25) , E. avium, and E. durans (5, 6, 10) . We identified clinical enterococcal isolates to the species level and determined their resistance phenotypes. We used these isolates to evaluate the Vitek system (bioMerieux Inc., Hazelwood, St Louis, Mo.) by using software version 7.1 to detect vancomycin-resistant enterococci (VRE). In a previous evaluation (26) , we found that the Vitek system with computer software version 6.1 had an unacceptably low level of sensitivity (72%) for VRE detection. In addition, we evaluated the ability of the Vitek GPI card to correctly identify the species within the genus Enterococcus.
We selected 374 clinical enterococcal isolates so as to include a large number of VRE (67%) with a variety of glycopeptide resistance phenotypes. The majority of VRE were from cultures of blood, urine, and wound specimens from patients in New York City hospitals, whereas susceptible strains were mostly from oncology patients in Princess Margaret Hospital, Toronto, Ontario, Canada. The control organisms used in the study were E. raffinosis ATCC MICs were determined by the agar dilution methodology of the National Committee for Clinical Laboratory Standards (17, 18), and identification of enterococci to the species level was performed by using the conventional biochemical methods described by Facklam and colleagues (3, 4) . The organisms were tested by using the Vitek GPI and GPS-TA cards in accordance with the manufacturer's instructions. The data accumulated by the Vitek reader system were interpreted by the revised computer software, version 7.1. Vitek results were compared with those obtained by reference methods, and from these comparisons we calculated sensitivities, specificities, and error rates (16) for the software version. For the purposes of the sensitivity and specificity calculations, all strains determined to be in the intermediate van- comycin category, either by agar dilution or by the Vitek system, were combined with those isolates determined to be resistant by these systems. For the purpose of the present study, the vancomycin resistance phenotypes of Quintiliani et al. (20) gallinarum, E. casseliflavus, and E. mundtii. Therefore, when using this system, it would be prudent to suspect that one of these species is an enterococcal isolate if the vancomycin MIC for the isolate is 8.0 p,g/ml, and in such cases, the minimum requirements for further identification should be a tube motility test in semisolid medium incubat'ed at 30°C for up to 72 h as well as the close examination of colonies for the production of a yellow pigment, which is best detected with a cotton swab (3, 4) . Conversely, if a yellow pigment is detected, motility as well as MIC testing should be performed.
The resistance phenotypes, as determined by agar dilution susceptibility testing of vancomycin and teicoplanin, are summarized in Table 2 . Class A VRE, which are known to be mediated by the vanA gene cluster (2, 13, 27) , appear to be the most prevalent VRE (87%) in the New York City area (12) . A source of great concern is the presence of class A resistance, as confirmed by vanA probing (data not shown), in the two isolates of E. mundtii and those VRE which we were unable to identify to the species level. To the best of our knowledge, high-level vancomycin resistance in such strains (class C); (vancomycin MICs for all of these isolates were 8.0 ,ug/ml) and one strain each of E. faecium and E. faecalis (vancomycin MICs, 16 ,ug/ml; teicoplanin susceptible).
The sensitivity of the GPS-TA card for the detection of vancomycin resistance was found to be 98%, and the specificity was found to be an acceptable 95%. The error rates generated by the card were as follows: there were four very major errors among class A E. faecium isolates, resulting in very major error rates of 1.8% for E. faecium and 1.6% overall. The minor errors included two E. faecalis isolates that were susceptible by agar dilution but intermediate by testing with the Vitek system (on repeat Vitek testing, both isolates were susceptible), one E. faecium and one E. faecalis were intermediate by agar dilution but were called susceptible by Vitek, and one E. faecalis that was resistant by agar dilution was called intermediate by Vitek. These resulted in minor error rates of 0.4% for E. faecium and 3.5% for E. faecalis, with an overall minor error rate of 1.3%. No major errors were incurred, and there were no errors among isolates of other enterococcal species. The low-level vancomycin resistance of E. gallinanrm and E. casseliflavus was detected by the GPS-TA card in all cases. It appears that the vancomycin MICs fall within the intermediate category for very few E. faecalis or E. faecium strains (<1% of vancomycin-resistant isolates in the present study). The use of a screen plate containing 6 ,ug of vancomycin per ml detects such borderline isolates (26) .
In conclusion, we found evidence of a variety of vancomycin-resistant phenotypes among the New York City enterococcal isolates, although the majority of strains were of NOTES 2779 the class A resistance phenotype. We also found class A vancomycin resistance in two isolates of E. mundtii as well as in a number of strains that appeared to be either variants of existing species or isolates of novel enterococcal species. Identification of E. faecium and E. faecalis by the GPI card was found to be acceptable, although for species other than these, conventional methods are required for correct species identification. Detection of vancomycin resistance by the Vitek GPS-TA card in enterococci has been markedly improved by the updated software version 7.1 and should now be considered acceptable. Because the universal susceptibility of the enterococci to vancomycin can no longer be presumed, it is vitally important that laboratory procedures accurately identify resistant strains. If routine susceptibility testing is not performed on all enterococcal isolates, such as those from urine and wound specimens, it may be prudent to implement the use of the vancomycin screen plate (26 
